Cite
Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study.
MLA
García-Sánchez, Javier, et al. “Adjuvant Aromatase Inhibitor Treatment Worsens Depressive Symptoms and Sleep Quality in Postmenopausal Women with Localized Breast Cancer: A One-Year Follow-up Study.” Breast (Edinburgh, Scotland), vol. 66, Dec. 2022, pp. 310–16. EBSCOhost, https://doi.org/10.1016/j.breast.2022.11.007.
APA
García-Sánchez, J., Mafla-España, M. A., Torregrosa, M. D., & Cauli, O. (2022). Adjuvant aromatase inhibitor treatment worsens depressive symptoms and sleep quality in postmenopausal women with localized breast cancer: A one-year follow-up study. Breast (Edinburgh, Scotland), 66, 310–316. https://doi.org/10.1016/j.breast.2022.11.007
Chicago
García-Sánchez, Javier, Mayra Alejandra Mafla-España, María Dolores Torregrosa, and Omar Cauli. 2022. “Adjuvant Aromatase Inhibitor Treatment Worsens Depressive Symptoms and Sleep Quality in Postmenopausal Women with Localized Breast Cancer: A One-Year Follow-up Study.” Breast (Edinburgh, Scotland) 66 (December): 310–16. doi:10.1016/j.breast.2022.11.007.